缺血性脑卒中患者二级预防用药依从性的现状研究

目的调查我医院缺血性脑卒中(ischemic stroke,IS)患者二级预防用药依从性的现状及影响因素。方法采用访谈形式,收集因IS在我院住院的患者出院1年来二级预防用药情况。结果 81例我院IS患者中,抗血小板聚集、降脂药的依从性分别为72.8%、49.3%,合并高血压、糖尿病患者降压、降糖药依从性分别为77.6%、70.6%。结论 IS患者二级预防中抗血小板、降脂、降压、降糖药物的应用都未达标,其中降脂药依从性依从性最差。医疗付费方式是影响我院IS患者依从性的独立危险因素。

Status of Secondary Prevention Drug Adherence in Ischemic Stroke Patients

Objective To investigate secondary prevention drug adherence of ischemic stroke （ischemic stroke, IS） patients in our hospital and the influential factors of it. Methods Using interview form to collect medication data of IS patients during the period of 1 year, who were discharged from our hospital. Results In 81 cases patients of our hospital, the adherence of anti-platelet aggregation, lipid-lowering drugs was 72.8%, 49.3%respectively, and the adherence of antihypertensive, antidiabetic drug were 77.6%, 70.6%to patients with hypertension and diabetes. Conclusion The drug adherence of IS patients with antiplatelet, lipid-lowering, antihypertensive, hypoglycemic drug were substandard, and the adherence of lipid-lowering drug is the worst. The medical payment method was independent risk factor affecting drug adherence of patients.